DK2658873T3 - Tværbindende polypeptid omfattende et tetramerisk enkeltkæde-antistof, der binder et MHC-MAGE-kompleks, der inducerer apoptose - Google Patents
Tværbindende polypeptid omfattende et tetramerisk enkeltkæde-antistof, der binder et MHC-MAGE-kompleks, der inducerer apoptose Download PDFInfo
- Publication number
- DK2658873T3 DK2658873T3 DK11820899T DK11820899T DK2658873T3 DK 2658873 T3 DK2658873 T3 DK 2658873T3 DK 11820899 T DK11820899 T DK 11820899T DK 11820899 T DK11820899 T DK 11820899T DK 2658873 T3 DK2658873 T3 DK 2658873T3
- Authority
- DK
- Denmark
- Prior art keywords
- mage
- mhc
- binds
- complex
- single chain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061460213P | 2010-12-27 | 2010-12-27 | |
US201161572318P | 2011-07-13 | 2011-07-13 | |
PCT/NL2011/050893 WO2012091564A2 (en) | 2010-12-27 | 2011-12-22 | A cross-linking polypeptide that induces apoptosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2658873T3 true DK2658873T3 (da) | 2019-11-25 |
Family
ID=45771867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11820899T DK2658873T3 (da) | 2010-12-27 | 2011-12-22 | Tværbindende polypeptid omfattende et tetramerisk enkeltkæde-antistof, der binder et MHC-MAGE-kompleks, der inducerer apoptose |
Country Status (7)
Country | Link |
---|---|
US (3) | US9512231B2 (da) |
EP (2) | EP3613773A1 (da) |
JP (1) | JP6177137B2 (da) |
AU (1) | AU2011353197B2 (da) |
CA (1) | CA2822939A1 (da) |
DK (1) | DK2658873T3 (da) |
WO (1) | WO2012091564A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011353197B2 (en) | 2010-12-27 | 2017-04-20 | Apo-T B.V. | A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis |
CA2822938A1 (en) | 2010-12-27 | 2012-07-05 | Apo-T B.V. | A polypeptide that binds aberrant cells and induces apoptosis |
EP2760892A1 (en) * | 2011-09-29 | 2014-08-06 | Apo-T B.V. | Multi-specific binding molecules targeting aberrant cells |
EP2802356A1 (en) | 2012-01-13 | 2014-11-19 | Apo-T B.V. | Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
US9732146B2 (en) | 2012-03-30 | 2017-08-15 | The United States Of America As Represented By The Department Of Veterans Affairs | Antibody-mediated transduction of heat shock proteins into living cells |
EP2864354A1 (en) | 2012-06-26 | 2015-04-29 | Apo-T B.V. | Binding molecules targeting pathogens |
AU2014360273A1 (en) * | 2013-12-06 | 2016-06-02 | Dana-Farber Cancer Institute, Inc. | Therapeutic peptides |
WO2015123359A1 (en) * | 2014-02-11 | 2015-08-20 | Albany Medical College | Multi-functional mucosal vaccine platform |
CA2992298A1 (en) | 2015-07-23 | 2017-01-26 | Inhibrx Lp | Multivalent and multispecific gitr-binding fusion proteins |
JPWO2019151392A1 (ja) * | 2018-01-31 | 2021-02-04 | 国立大学法人東北大学 | 抗原特異的mhc発現調節法 |
SG11202103990QA (en) | 2018-10-22 | 2021-05-28 | Janssen Pharmaceutica Nv | Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7527787B2 (en) * | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
CA2476625A1 (en) * | 2002-02-20 | 2003-08-28 | Dyax Corp. | Mhc-peptide complex binding ligands |
EP1517921B1 (en) * | 2002-06-28 | 2006-06-07 | Domantis Limited | Dual specific ligands with increased serum half-life |
JP2006523437A (ja) * | 2002-12-03 | 2006-10-19 | アヴィデックス リミテッド | レセプター複合体 |
AU2005251563B2 (en) * | 2004-06-09 | 2011-08-04 | Technion Research & Development Foundation Ltd. | Antibodies for selective apoptosis of cells |
CN101379083A (zh) | 2005-12-20 | 2009-03-04 | 鹿特丹伊拉斯姆斯大学医疗中心 | 诱导凋亡的蛋白质复合物以及其治疗应用 |
AU2011353197B2 (en) | 2010-12-27 | 2017-04-20 | Apo-T B.V. | A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis |
CA2822938A1 (en) | 2010-12-27 | 2012-07-05 | Apo-T B.V. | A polypeptide that binds aberrant cells and induces apoptosis |
EP2760892A1 (en) * | 2011-09-29 | 2014-08-06 | Apo-T B.V. | Multi-specific binding molecules targeting aberrant cells |
EP2802356A1 (en) * | 2012-01-13 | 2014-11-19 | Apo-T B.V. | Aberrant cell-restricted immunoglobulins provided with a toxic moiety |
-
2011
- 2011-12-22 AU AU2011353197A patent/AU2011353197B2/en not_active Ceased
- 2011-12-22 DK DK11820899T patent/DK2658873T3/da active
- 2011-12-22 CA CA2822939A patent/CA2822939A1/en not_active Abandoned
- 2011-12-22 EP EP19192361.4A patent/EP3613773A1/en not_active Withdrawn
- 2011-12-22 JP JP2013547377A patent/JP6177137B2/ja active Active
- 2011-12-22 US US13/976,952 patent/US9512231B2/en active Active
- 2011-12-22 EP EP11820899.0A patent/EP2658873B1/en not_active Not-in-force
- 2011-12-22 WO PCT/NL2011/050893 patent/WO2012091564A2/en active Application Filing
-
2016
- 2016-11-08 US US15/346,445 patent/US20170114144A1/en not_active Abandoned
-
2018
- 2018-10-04 US US16/151,623 patent/US20190085090A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2658873A2 (en) | 2013-11-06 |
US9512231B2 (en) | 2016-12-06 |
WO2012091564A3 (en) | 2012-08-23 |
JP6177137B2 (ja) | 2017-08-09 |
EP2658873B1 (en) | 2019-08-21 |
EP3613773A1 (en) | 2020-02-26 |
JP2014505471A (ja) | 2014-03-06 |
US20170114144A1 (en) | 2017-04-27 |
US20190085090A1 (en) | 2019-03-21 |
CA2822939A1 (en) | 2012-07-05 |
AU2011353197A1 (en) | 2013-07-18 |
WO2012091564A2 (en) | 2012-07-05 |
AU2011353197A8 (en) | 2013-12-19 |
AU2011353197B2 (en) | 2017-04-20 |
US20140120090A1 (en) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2658873T3 (da) | Tværbindende polypeptid omfattende et tetramerisk enkeltkæde-antistof, der binder et MHC-MAGE-kompleks, der inducerer apoptose | |
IL261242A (en) | Mice with reduced immunoglobulin heavy chain | |
DK3378535T3 (da) | Humanserede antistoffer, der genkender alpha-synuklein | |
DK2954779T3 (da) | Mus, der frembringer tungkædeantistoffer | |
DK2766395T3 (da) | Antistofpolypeptider, der antagoniserer cd40l | |
LT2734549T (lt) | Monokloninis antikūnas prieš šuns interleukiną-31 | |
BRPI1010297A2 (pt) | anticorpos biespecíficos trivalentes. | |
DK2521736T3 (da) | Humaniserede antistoffer | |
IL221408A0 (en) | Monoclonal antibodies against c-met | |
DK2563400T3 (da) | Modificerede bindeproteiner, der hæmmer VEGF-A-receptorinteraktion | |
DK2847231T3 (da) | Multispecifikke monoklonale antistoffer | |
DK2794905T3 (da) | Modificerede polypeptider til bispecifikke antistofgrundstrukturer | |
BR112012002226A2 (pt) | anticorpos muc1. | |
BR112012030311A2 (pt) | anticorpo | |
DK2807188T3 (da) | Humaniserede antistoffer, der genkender alpha-synuclein | |
DK2912183T3 (da) | Pr13.5-promotor til robuste t-celle- og antistofresponser | |
DK2964258T3 (da) | Antistoffer, der binder IL-23 | |
HK1208236A1 (en) | Antigen binding proteins that bind ccr2 ccr2 | |
DK2658872T3 (da) | Polypeptid, der binder aberrerende celler og inducerer apoptose | |
BR112013016917A2 (pt) | ligantes que ligam receptor de tgf-beta ii. | |
EP2646054A4 (en) | METHODS OF TREATING A TUMOR USING ANTIBODY THAT IS SPECIFICALLY BOUND TO GRP94 | |
DK3351255T3 (da) | Modificerede anti-cd4-antistoffer | |
DK3246339T3 (da) | Antistoffer mod bradykinin-b1-receptorligander | |
DK3085777T3 (da) | Polypeptid | |
EP2707392A4 (en) | MONOCLONAL ANTIBODY FOR ACETYLAMANTADINE |